搜索临床试验以:非甾体芳香化酶抑制剂 (NSAI)
总计2551个结果
-
NSABP Foundation IncRoyal Marsden NHS Foundation Trust; Pfizer; Institute of Cancer Research, United Kingdom完全的乳腺癌 | 乳腺肿瘤 | 乳腺癌英国, 美国, 加拿大
-
Universitaire Ziekenhuizen KU LeuvenEli Lilly and Company; European Network of Gynaecological Oncological Trial Groups (ENGOT); Kom...招聘中
-
The University of Hong KongPrincess Margaret Hospital, Canada; Kwong Wah Hospital; Pamela Youde Nethersole Eastern Hospital; The Queen Elizabeth Hospital招聘中
-
Swiss GO Trial GroupHoffmann-La Roche; Novartis Pharmaceuticals; AGO Study Group; Anticancer Fund, Belgium; Arbeitsgemeinschaft... 和其他合作者招聘中输卵管肿瘤 | 腹膜肿瘤 | 卵巢肿瘤上皮 | 高级别浆液性卵巢癌 (HGSOC) | 低级别浆液性卵巢癌 (LGSOC) | 卵巢子宫内膜样癌奥地利, 瑞士, 德国
-
IRCCS Azienda Ospedaliera Universitaria San Martino...主动,不招人
-
University of CincinnatiUnited States Department of Defense完全的
-
Ente Ospedaliero Ospedali GallieraFondazione Policlinico Universitario Agostino Gemelli IRCCS; Istituto Di Ricerche Farmacologiche... 和其他合作者终止
-
Tianjin Medical University未知
-
Bristol-Myers Squibb完全的
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)招聘中
-
Heilongjiang University of Chinese MedicineMinistry of Science and Technology of the People´s Republic of China未知
-
Pfizer终止
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
National Cancer Institute (NCI)终止IV 期乳腺癌 | 复发性乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阳性 | HER2/Neu 阴性 | 男性乳腺癌美国
-
Pfizer主动,不招人乳腺肿瘤中国, 台湾, 香港, 新加坡, 泰国
-
UNICANCER完全的
-
EQRx International, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups (ENGOT)撤销